Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company specializing in developing innovative treatments for cancer and diabetes. The company's lead product candidate, REQORSA (GPX-001), is designed to address non-small cell lung cancer and small cell lung cancer. Additionally, Genprex is working on GPX-002, a preclinical stage gene therapy targeting diabetes. By focusing on gene therapy, the company aims to generate revenue through the development and commercialization of these advanced therapies, potentially providing new treatment options for patients with these conditions.

Products

• REQORSA (GPX-001) for non-small cell lung cancer and small cell lung cancer

• GPX-002, a preclinical stage gene therapy for diabetes